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ExocystExtracellular signal-regulated kinase (ERK) signals play important roles in cell death and survival. However, the
role of ERK in the repair process after injury remains to be deﬁned in the kidney. Here, we investigated the role of
ERK in proliferation and differentiation of tubular epithelial cells, and proliferation of interstitial cells following
ischemia/reperfusion (I/R) injury in the mouse kidney. Mice were subjected to 30 min of renal ischemia. Some
mice were administered with U0126, a speciﬁc upstream inhibitor of ERK, daily during the recovery phase, be-
ginning at 1 day after ischemia until sacriﬁce. I/R caused severe tubular cell damage and functional loss in the
kidney. Nine days after ischemia, the kidney was restored functionally with a partial restoration of damaged tu-
bules and expansion of ﬁbrotic lesions. ERK was activated by I/R and the activated ERK was sustained for 9 days.
U0126 inhibited the proliferation, basolateral relocalization of Na,K-ATPase and lengthening of primary cilia in
tubular epithelial cells, whereas it enhanced the proliferation of interstitial cells and accumulation of extra-
cellular matrix. Furthermore, U0126 elevated the expression of cell cycle arrest-related proteins, p21 and
phospholylated-chk2 in the post-ischemic kidney. U0126 mitigated the post-I/R increase of Sec10 which
is a crucial component of exocyst complex and an important factor in ciliogenesis and tubulogenesis.
U0126 also enhanced the expression of ﬁbrosis-related proteins, TGF-β1 and phosphorylated NF-κB after
ischemia. Our ﬁndings demonstrate that activation of ERK is required for both the restoration of damaged
tubular epithelial cells and the inhibition of ﬁbrosis progression following injury.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Acute kidney injury (AKI) is a signiﬁcant world-wide problem [1].
Mortality and morbidity by AKI in critically ill patients exceed 50% in
some studies and these rates have not declined over the last several
decades [2,3]. Ischemia/reperfusion (I/R) injury is one of the most
common causes of AKI and occurs in many clinical settings including
kidney transplantation and cardiac bypass surgeries [4]. The kidney
is composed of many types of cells, including epithelial cells in the
tubules and ﬁbroblasts in the interstitium. Depending on the cell
type and the time period following injury, cells display diverse path-
ological changes including: loss of cell polarity, disruption of cell to
cell contacts, death, proliferation, dedifferentiation, accumulation
of extracellular matrix (ECM), and proliferation of interstitial cells
[5]. In a recent study, we found that the kidney responded differentlyyungpook National University
22, Republic of Korea. Tel.:+82
l rights reserved.to antioxidant treatment depending on the starting time and dura-
tion of treatment, as well as the cell-type, resulting in differential
consequences with respect to repair following I/R injury [6].
Mitogen-activated protein kinases (MAPK), including p38, c-Jun
NH2-terminal kinase (JNK), and extracellular signal-regulated kinase
(ERK) play an important role in the survival and death in cells [7–9]. In a
previous study, we found that I/R dramatically increased the phosphor-
ylated ERK level in the kidney and the increased ERK levelwas sustained
until 9 days later, when renal function, but not morphology, returned to
approximately baseline [10]. This study suggests that ERK activation in
the recovery period may be associated not only with the process of
restoration of damaged tubular epithelial cells, but also increases in in-
terstitial ﬁbroblasts [10]. Furthermore, it suggests that the ERK signal
may act cell-speciﬁcally and in a time-dependent manner in the repair
following injury. However, the in vivo direct role of ERK remains to be
deﬁned in the recovery process following kidney I/R injury.
In the present study we investigated the role of ERK in tubular
epithelial cell restoration and ﬁbrotic changes following I/R injury
in mice including: proliferation, primary ciliogenesis, polarity of tu-
bular epithelial cells, proliferation of interstitial cells, and interstitial
1999H.-S. Jang et al. / Biochimica et Biophysica Acta 1832 (2013) 1998–2008ECM accumulation. Here, we report that prevention of ERK activation
by U0126, a speciﬁc inhibitor of MEK, which is directly upstream of
ERK, retarded restoration of tubular epithelial cells, and accelerated
ﬁbrosis via increases in interstitial cell proliferation and ECM accu-
mulation. These ﬁndings demonstrate for the ﬁrst time in vivo that
ERK contributes to the recovery following ischemic injury in the
mouse kidneys, suggesting that the modulation of ERK may be ther-
apeutically useful for the treatment of acute kidney injury and pro-
gression to ﬁbrosis.
2. Materials and methods
2.1. Animal preparation
All experiments were conducted using 8-week-old C57BL/6 male
mice weighing 20 to 25 g (Koatech, Gyounggido, Korea). The studies
were approved by the Institutional Animal Care and Use Committee of
Kyungpook National University. Mice were permitted free access to
water and standard mouse chow. The animals were anesthetized with
pentobarbital sodium (60 mg/kg body weight; Sigma; St. Louis, MO)
prior to surgery. Kidney ischemia was induced as described previously
[10]. In brief, kidneys were exposed via ﬂank incisions. The mice were
subjected either to 30 min of bilateral or unilateral renal ischemia
with non-traumatic microaneurysm clamps (Roboz Surgical Instru-
ments;Washington D.C.). The incisions were closed temporarily during
ischemia. After the removal of the clamps, reperfusionwas visually con-
ﬁrmed. Body temperature was maintained at 36.5–37.5 °C during the
operation. Some of the mice received intra-peritoneal administration
of U0126 (10 mg/kg BW; Selleckchem, Houston, TX) or vehicle begin-
ning at 24 h after I/R or sham until 24 h prior to harvest daily. To eval-
uate the accumulation of proliferating cell in the kidney, mice were
treated with 5-bromo-2-deoxyuridine (BrdU, 50 mg/kg body weight;
Sigma, St. Louis, MO) beginning at 24 h after I/R or sham until 24 h
prior to harvest daily [11]. Sham surgery was equivalent to the opera-
tion for ischemia except for clamping of the renal pedicle. To perform
biochemical and histological experiments, kidneys were snap-frozen
in liquid nitrogen and perfusion-ﬁxed with 30 mL of phosphate buff-
ered saline (PBS) for 2 min and then PLP (4% paraformaldehyde,
75 mM L-lysine, 10 mM sodium periodate; Sigma) solution, respective-
ly. Frozen tissue was kept in the deep-freezer until use.
2.2. Plasma creatinine concentration
The concentrations of plasma creatinine were measured using a
Vitros250 (Johnson and Johnson) [12].
2.3. Histology
Perfusion-ﬁxed kidneys were excised and placed in PLP overnight at
4 °C. Tissue samples were then cut into 4-μm parafﬁn-embedded sec-
tions using a microtome (Leica, Bensheim, Germany). Kidney-sections
were stained with periodic acid Schiff (PAS) or Masson trichrome
according to a standard protocol. Collagen deposition was quantiﬁed
using the i-solution DT image acquisition and analysis program (iMT
i-solution, Vancouver, Canada), incorporating a Nikon Fx35 (Nikon,
Japan) in 10 ﬁelds in the outer medulla per kidney [13]. Morphological
damage levels in PAS-stained kidney section were scored as described
previously [14]. Brieﬂy, ﬁfty tubules in the outer medullary region of
the kidneywere analyzed using a score of 0, no damage; 1,mild damage
with rounding of epithelial cells and a dilated tubular lumen; 2, severe
damage with ﬂattened epithelial cells, loss of nuclear staining, a dilated
lumen, and congestion of the lumen; and 3, destroyed tubules with ﬂat
epithelial cells lacking nuclear staining and congestion of the lumen. At
least four kidneys from each experimental condition were used. Ten
ﬁelds per slide were used for the counting. Pictures were taken in the
outer medulla.2.4. Measurement of primary cilia length
Kidney sections were processed for immunoﬂuorescence mi-
croscopy by staining with anti-acetylated α-tubulin antibody and
DAPI as described above. Images were captured using Axioplan-2
epiﬂuorescence microscope (Carl Zeiss, Thornwood, NY). 5–10
ﬁelds in the cortex were randomly captured (400×) and measured
in each segment per time point from 3 independent animals. More
than 50 cells from each experiment were used to measure cilia
length. iSolution (iMT i-Solution, Vancouver, Canada) software
was used to trace and measure the length of cilia in captured
images.
2.5. Western blot
Western blot analyses were performed as described previously
[12]. Antibodies used were; phospho-ERK (Cell Signaling Technology,
Danvers, MA), total-ERK (Cell Signaling Technology, Danvers, MA), col-
lagen I (Santa Cruz Biotechnology, Santa Cruz, CA), α-SMA (Sigma, St.
Louis, MO), Na,K-ATPase [15], Sec10 [16], TGF-β1 (Santa Cruz Bio-
technology, Santa Cruz, CA), ﬁbronectin (Santa Cruz Biotechnology,
Santa Cruz, CA), p-NF-κB (Cell Signaling Technology, Danvers, MA),
Ly6G (eBioscience, San Diego, CA), p21 (Santa Cruz Biotechnology,
Santa Cruz, CA), p-chk2 (Cell Signaling Technology, Danvers, MA)
and GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA) as a marker
for protein loading. LabWorks software (UVP, Upland, CA) was
used for quantiﬁcation of band densities.
2.6. Immunoﬂuorescence and immunohistochemistry staining
Immunoﬂuorescence and immunohistochemistry staining were
performed as described previously [13,17]. Antibodies used were:
BrdU (Serotec, Oxford, UK), acetylated tubulin (Sigma, St. Louis, MO),
Na,K-ATPase [15,18], FSP-1 (Novus, Littleton, CO) and p21 (Santa Cruz
Biotechnology, Santa Cruz, CA). Sections were observed under an LSM
5 confocal microscope (Carl Zeiss, Thornwood, NY) or an Axioplan-2
epiﬂuorescence microscope (Carl Zeiss, Thornwood, NY) or Nikon
Fx35 (Nikon, Japan). Pictures were taken in the outer medulla.
2.7. Statistics
Results were expressed as the means ± SEM. Statistical differ-
ences among groups were calculated using Student's t-test. Each
experimental group consisted of at least three mice. Differences be-
tween groups were considered statistically signiﬁcant at a P value of
b0.05.
3. Results
3.1. Increased plasma creatinine levels after I/R gradually return to the
normal range, whereas ﬁbrotic lesion is expanded over time
Consistent with our previous studies [6,10,12,15], the concentra-
tion of plasma creatinine (PCr) was signiﬁcantly elevated 24 h fol-
lowing 30 min of bilateral renal ischemia (Fig. 1A). The increased
PCr returned to approximately normal ranges by post-ischemic day
9 (Fig. 1A). Kidneys exposed to 30 min of ischemia in mice had dis-
ruption and loss of brush border of tubular epithelial cells with atro-
phy, dilation, and congestion of tubules (Fig. 1B). The tubular
damage score peaked at 24 h after ischemia and then gradually de-
creased over time, whereas the ﬁbrotic lesions gradually increased
over the time period (Fig. 1B and C). Collagen deposition and
α-SMA expression signiﬁcantly increased in the kidneys exposed to
ischemia, and these increases were gradual over time (Fig. 1C and
D). Fibronectin is associated with the process of repair, including ﬁ-
brosis [19–21]. The expression of ﬁbronectin gradually increased
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Fig. 1. Time course of plasma creatinine, tubular damage, and collagen deposition after ischemic injury in the kidney. Mice were subjected to either 30 min of bilateral renal ischemia (Ischemia) or sham surgery (Sham). (A) Plasma creatinine
concentrations were measured at the indicated time points. (B) Tubular damage score and (C) collagen deposition were measured at the indicated time points. The evaluation of tubular damage and collagen deposition involved averaging
the values from 10 ﬁelds per kidney. (B, C) Kidneys were harvested at the indicated time points after the operations and examined with periodic acid-Schiff and trichrome staining as described in the Materials and methods section. Collagen
deposition by Masson's trichrome staining is shown by the blue color. Pictures were obtained from the outer medulla. PAS- and trichrome-stained images were representative of the indicated time points. (D) Western blot was performed
using antibodies against ﬁbronectin, α-SMA, and Ly6G. The density of the bands was quantiﬁed using LabWorks analysis software. GAPDH was used as a loading control. FN = ﬁbronectin. Scale bar indicates 50 μm. The results are expressed
as the means ± SEM (n = 4–6). *, P b 0.05 vs. sham.
2000
H
.-S.Jang
et
al./
Biochim
ica
et
Biophysica
A
cta
1832
(2013)
1998
–2008
01
2
3
4
0
1
2
3
4
5
0
2
4
6
8
10
12
14
0 2 4 6 8 10
0
2
4
6
8
10
12
14
0 2 4 6 8 10
0
2
4
6
8
10
12
14
16
18
20
p
-
E
R
K
 
a
n
d
 
t
-
E
R
K
 
e
x
p
r
e
s
s
i
o
n
 
(
v
s
.
 
d
a
y
 
0
)
p-ERK
GAPDH
3Sham
Time (day) after ischemia
91
t-ERK
Time (day) after ischemia
36
42
44
42
44
B
R
a
t
i
o
 
o
f
 
p
-
E
R
K
 
t
o
 
t
-
E
R
K
(
v
s
.
 
d
a
y
 
0
)
U0126VehU0126Veh
IschemiaSham
36
42
44
42
44
p-ERK
GAPDH
t-ERK
Time (day) after ischemia
A
R
a
t
i
o
 
o
f
 
p
-
E
R
K
 
t
o
 
t
-
E
R
K
(
v
s
.
v
e
h
i
c
l
e
-
t
r
e
a
t
e
d
 
s
h
a
m
)
Sham Ischemia
†
U0126
Vehicle
Sham Ischemia
U0126
Vehicle
†
U0126
Vehicle
p
-
E
R
K
 
e
x
p
r
e
s
s
i
o
n
(
v
s
.
v
e
h
i
c
l
e
-
t
r
e
a
t
e
d
 
s
h
a
m
)
t
-
E
R
K
 
e
x
p
r
e
s
s
i
o
n
(
v
s
.
v
e
h
i
c
l
e
-
t
r
e
a
t
e
d
 
s
h
a
m
)
Sham Ischemia
t-ERK
p-ERK
1 3 5 7 91 3 5 7 9
*
*
*
*
*
***
*
*
* *
*
*
Fig. 2. Sustained activation of ERK after ischemic injury in the kidney. Mice were subjected to either 30 min of unilateral renal ischemia (Ischemia) or sham surgery (Sham). Some mice received U0126, an inhibitor of MEK, daily from 24 h
after the operation to 24 h prior to the harvest. Kidneys were harvested at the indicated time points, or 9 days after the operations, and western blot analysis was performed as described in the Materials and methods section. (A and B)
Western blot bands, shown in duplicate, were representative for the indicated time points. The densities of phospholylated-ERK (p-ERK) and total-ERK (t-ERK) were quantiﬁed using LabWorks analysis software. GAPDHwas used as a loading
control. Veh = vehicle. The results were expressed as the means ± SEM (n = 5). *, P b 0.05 vs. sham; †, P b 0.05 vs. vehicle-treated ischemia.
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markedly increased at early time-points and this increase was
sustained for longer than 16 days (Fig. 1D).
3.2. ERK activated by ischemia is present for a long period of time
To minimize the effect of uremia on ERK activation, we determined
ERK activation in a mouse model of unilateral ischemia, which does not
develop uremia [10]. 30 min of unilateral renal ischemia dramatically
increased active phospholylated ERK (p-ERK) levels (Fig. 2A). The in-
crease of p-ERK peaked at 3 days after ischemia and gradually de-
creased over time. However, the increased p-ERK level did not return
to normal levels until 9 days after ischemia (Fig. 2A). Total ERK levels
increased gradually until 9 days after ischemia (Fig. 2A). The ratio of
p-ERK to t-ERK in the I/R-injured kidneys was higher than that in the
sham-operated kidneys (Fig. 2A). Treatment with U0126, a speciﬁc in-
hibitor of MEK, beginning at 24 h after ischemia daily, signiﬁcantly
prevented the increase of p-ERK, but not t-ERK (Fig. 2B).
3.3. Inhibition of ERK activation retards restoration of damaged tubules,
whereas it enhances ﬁbrosis
Nine days after ischemia, tubular atrophy, dilation, and congestion
of tubules were signiﬁcantly greater in the U0126-treated mouse kid-
neys than in the vehicle-treated mouse kidneys (Fig. 3A). The number
of interstitial cells also was greater in the U0126-treated mouse kid-
neys when compared with that in the vehicle-treated mouse kidneys
(Fig. 3A). Consistent with the morphological evaluation, tubular dam-
age scores were signiﬁcantly higher in the U0126-treated mouse0.0
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Fig. 3. Delayed epithelial cell recovery and accelerated progression of ﬁbrosis by inhibition o
sham surgery (Sham). Kidneys were harvested at 9 days following ischemia. Some mice rece
harvest. (A) To evaluate tubular damage, kidney sections were stained with periodic acid-Sc
from the outer medulla. The score of tubular damage was a result of averaging the values fr
posed to trichrome staining as described in the Materials and methods section. Collagen
obtained from the outer medulla. The area of collagen deposition was determined by aver
bar indicates 50 μm. The results were expressed as the means ± SEM (n = 5). *, P b 0.05 vkidneys than in the vehicle-treated mouse kidneys (Fig. 3A). Collagen
deposition in the U1026-treated mouse kidneys was also much great-
er than in the vehicle-treated mouse kidneys 9 days following ische-
mia (Fig. 3B).3.4. Inhibition of ERK activation decreases proliferation of tubular epithelial
cells, whereas it accelerates proliferation of interstitial cells
To detect proliferating cells in the kidney, we administered BrdU
daily into mice beginning at 24 h after ischemia until sacriﬁce. BrdU-
positive cells in the tubules and interstitium of the sham-operated
mouse kidney were rarely observed (Fig. 4A and B). On the other
hand, 9 days after ischemia, the numbers of BrdU-positive cells were
signiﬁcantly increased in both the tubules and the interstitium when
compared with the sham-operated kidneys (Fig. 4A and B). The
post-ischemic increase of BrdU-positive cells in the kidney tubules
was signiﬁcantly less in the U0126-treated mouse kidneys than in the
vehicle-treated kidneys (Fig. 4A). As opposed to the results in tubules,
the number of BrdU-positive cells in the interstitium was greater in
the kidneys of U0126-treated mice than that of vehicle-treated mice
9 days after I/R (Fig. 4B). Expression of p21 and p-chk2 induces cell
cycle arrest, G1/S or G2/M arrest, which is associated with kidney ﬁbro-
sis progression [22–26]. Post-ischemic expression of p21 and p-chk2
was highly upregulated in the post-ischemic kidneys, compared to the
sham-operated kidneys (Fig. 4C). Moreover, tubular localization of
p21was also increased in the post-ischemic kidneys, and its localization
was greater in the U0126-treated I/R-injured kidneys than that in the
vehicle-treated kidneys (Fig. 4D), suggesting that the deterioration of0
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Fig. 4. Effect of inhibition of ERK in the cell proliferation of ischemic kidneys. Mice were subjected to either 30 min of unilateral renal ischemia (Ischemia) or sham surgery (Sham). Some mice received U0126, an inhibitor of MEK, daily from
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treatment is related to tubular cell cycle arrest.3.5. Inhibition of ERK activation retards basolateral relocalization of Na,
K-ATPase, lengthening of primary cilia, and increase of Sec10 expression
after I/R
Expression of Na/K-ATPase, which is an important membrane
transporter and is localized on the basolateral membrane, is a criti-
cal factor for the restoration of polarity in the tubular epithelial
cell [27]. Nine days after ischemia, the amount of Na,K-ATPase ex-
pression in the I/R-injured kidney was signiﬁcantly decreased com-
pared with that in the non-I/R-injured kidney and the decrease was
much greater in the U0126-treated mouse kidneys than that in the
vehicle-treated mouse kidneys (Fig. 5A). In the sham-operated kid-
neys, Na,K-ATPase was localized basolaterally in a stripe pattern in
proximal tubular epithelial cells (Fig. 5B). U0126-treatment in the
sham-operated kidney did not affect the distribution (Fig. 5B). In
the ischemic injured kidneys, Na,K-ATPase was much fainter and
distributed over the entire cell membrane of proximal tubular epi-
thelial cells (Fig. 5B). The change of Na,K-ATPase expression after
I/R was much greater in the U0126-treated compared with the
vehicle-treated mouse kidneys (Fig. 5).
Primary cilia protruded from the apical surface into the lumen
(Fig. 6A). Primary cilia are shortened or disappear in the injury peri-
od following I/R and then lengthen during the recovery period [28].
Nine days after ischemia, primary cilia lengths were signiﬁcantly
longer when compared with those in the sham-operated control
kidney (Fig. 6A). Primary cilia lengths in the U0126-treated mouse
kidneys were signiﬁcantly shorter than those in vehicle-treated
mouse kidneys 9 days after ischemia (Fig. 6A). Sec10, a crucial com-
ponent of the exocyst complex, accelerates the recovery of damaged
epithelial cells and regulates the length of primary cilia via ERK acti-
vation [29]. I/R increased the expression of Sec10 in the kidney, but
the increase in Sec10 expression was signiﬁcantly less in the
U0126-treated mouse kidneys than in the vehicle-treated mouse
kidneys (Fig. 6B).0.0
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Fig. 5. Effect of inhibition of ERK in the expression of Na,K-ATPase in ischemic kidneys. Mice
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blot was performed using an anti-Na,K-ATPase antibody. The density of the bands was quanti
sections were stained using an antibody against Na,K-ATPase as described in the Materials and m
the outermedulla andwere representative of three individual experiments. Arrowhead indicates
bule. Scale bar indicates 10 μm. The results were expressed as the means ± SEM (n = 5). *, P b3.6. Inhibition of ERK increases expression of TGF-β1, activated-NF-κB,
and ﬁbrosis marker proteins in the kidney
Nine days after ischemia, the expression of TGF-β1 in the kidney
was signiﬁcantly greater than that found in the sham-operated
kidneys (Fig. 7A and B). The post-ischemic increase of TGF-β1 in the
U0126-treated mice was signiﬁcantly greater than in the vehicle-treated
mouse (Fig. 7A and B). Expression of collagen I, ﬁbronectin, and α-SMA
in the kidney subjected to ischemia was greater than that in the kidney
subjected to sham-operation (Fig. 7A and C–E). U0126 treatment further
enhanced the post-ischemic increase of collagen I, ﬁbronectin and
α-SMA (Fig. 7A and C–E). Ischemia increased the phosphorylation
of NF-κB (Fig. 7A and F) and the increase of phosphorylation of NF-κB
was signiﬁcantly enhanced by U0126 treatment (Fig. 7A and F). Consis-
tent with the activation of NF-κB, the expression of Ly6Gwas greater in
the U0126-treated ischemic kidneys than it was in the vehicle-treated
ischemic kidneys (Fig. 7A and G).
4. Discussion
In the present study, our major ﬁndings are that 1) ERK activated
by I/R injury lasted for a lengthy period of time following ischemia,
2) U0126 treatment during the recovery period retarded the restora-
tion of damaged tubular epithelial cells, whereas it accelerated the pro-
gression of ﬁbrosis, and 3) U0126 treatment inhibited the lengthening
of primary cilium, with the prevention of a post-ischemic ischemic in-
crease in exocyst Sec10 expression. Based on our ﬁndings, we conclude
that activated ERK during recovery plays a key role in both the restora-
tion of damaged tubular epithelial cells and the inhibition of ﬁbrosis
progression.
Tubular epithelial cells have a great capacity for recovery and re-
plenishment of damaged epithelial cells through proliferation and dif-
ferentiation of surviving epithelial cells, under the regulation of a
number of intrinsic temporally-expressed cellular signals [30–32]. ERK
has long been considered as a main modulator of kidney I/R injury by
regulating survival and death in the kidney, depending on the severity
of injury and treatment [10,15,33]. However, the direct role of ERK in
the repair after I/R injury in the kidney remains to be deﬁned. In theSham-Vehicle Sham-U0126
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2005H.-S. Jang et al. / Biochimica et Biophysica Acta 1832 (2013) 1998–2008present study, we found that I/R increased the activation and amount of
ERK, and these increases lasted until the kidney was functionally re-
stored. Several previous studies reported that chronic kidney injury, in-
cluding ischemic injury, activates ERK [34–36]. We also found that the
blockage of ERK activation using U0126 delayed the recovery of tubular
epithelial cells, and accelerated progression of ﬁbrosis. These data indi-
cate that ERKmay act in a cell-speciﬁc manner in the kidney during re-
covery following injury.
Recent studies have demonstrated that the ERK signaling path-
way is involved in anti-inﬂammatory and anti-oxidant effects in di-
verse cells [37–40]. Maeng et al. reported that ERK directly inhibits
NF-κB signaling, thereby suppressing the inﬂammation in endothelial
cells, which is critical for the regulation of inﬂammatory cells recruited
into damaged tissue [41]. In addition, we and others have reported that
ERK improves the survival of kidney epithelial cells following ischemia/
reperfusion injury, and oxidant injury is associated with progression of
ﬁbrosis [10,13,33]. In the present studywe found that ERK inhibition ac-
celerated leukocyte inﬁltration in the injured kidney with increased ac-
tivation of NF-κB. Therefore, the role of ERK in acute and chronic kidney
injurymay be associatedwith the anti-inﬂammatory and anti-oxidative
effects.
Jo et al. demonstrated that pretreatment with U0126 before an is-
chemic insult protects the kidney from ischemic injury [42]; however,
in the present study U0126 treatment worsened kidney ﬁbrosis. This
may be due to the timing of U0126 treatment. Jo et al. treated U0126mice before injury [42], whereas we administered U0126 after the
peak of injury, i.e., during the recovery phase. This may account for
the different results generated by Jo et al., and suggests that ERK
acts differently with respect injury and repair depending upon the
time of treatment and the cell type. Furthermore, recent reports
have suggested an association between kidney ﬁbrosis progression
and cell cycle arrest [5,23,24]. Yang and colleagues reported that
cell cycle arrest of acutely injured tubular epithelial cell worsens kid-
ney ﬁbrosis [25]. In the present study, expression of p21 and p-chk2,
cell cycle arrest markers, increased in post-ischemic kidney and these
increases were higher in the U0126-treated post-ischemic kidneys
than in the vehicle-treated post-ischemic kidneys. This suggests that
the worsened kidney ﬁbrosis caused by ERK inhibition in the ischemic
kidney, may be due, at least in part, to tubular cell cycle arrest.
Na,K-ATPase, one of themost prominent transmembrane proteins in
the tubular epithelial cell, is predominantly expressed on the
basolateral plasmamembrane, and is amajor contributor to themainte-
nance of cell polarity in the tubular epithelial cell [4,43]. The change in
distribution of Na,K-ATPase is closely related to the injury and differen-
tiation of cells. In previous studies, we found that the localization of Na,
K-ATPase was severely disrupted after I/R injury; in post-ischemic
kidneys the disruption was sustained for up to 8 days and then grad-
ually recovered over time [29]. In the present study, the alteration of
location and expression levels of Na,K-ATPase was similarly seen in the
I/R injured kidney and these changeswere greater in the U0126-treated
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2006 H.-S. Jang et al. / Biochimica et Biophysica Acta 1832 (2013) 1998–2008mouse kidneys than in the vehicle-treated mouse kidneys. These data
indicate that ERK1/2 activation is required for the restoration of Na,
K-ATPase bothmorphologically and quantitatively after I/R injury, indi-
cating that ERK1/2 activation is necessary for both the restoration of cell
polarity, disrupted by I/R injury, and for the prevention of undesirable
features of wound healing, such as ﬁbrosis. Recently Rajasekaran and
colleagues reported that treatmentwith TGF-β1,which is awell-known
inducer of ﬁbrosis, changes Na,K-ATPase localization and that the al-
tered Na,K-ATPase localization is associatedwith progression of ﬁbrosis
[44].
Alterations of cilia length are found in diverse pathophysiological
conditions including I/R and ureteral obstruction injury [28,45].
Verghese and colleagues reported that I/R injury in the kidneys in-
duces alterations of primary cilia length in a temporal pattern;
lengths of primary cilia are shortened early after I/R injury, lengthen
during recovery, and ﬁnally return to a normal size. Further, they re-
ported that the outcome of transplanted kidneys is associated with
changes of primary cilia length [45]. In the present study, we observed
that the length of primary cilia in the recovering tubular epithelial
cells was increased. We also found that the length of primary cilia inthe U0126-treated mouse kidneys was signiﬁcantly shorter than that
in the vehicle-treated mouse kidneys, indicating that ERK signals regu-
late the reconstruction of primary cilia altered by I/R injury, and conse-
quently lead to the restoration of damaged tubules. Recently, it has been
demonstrated that the activation of the ERK pathway is necessary for
primary ciliogenesis and tubulogenesis [29,46,47].
Accumulating in vitro evidence demonstrates that exocyst Sec10
mediates function in tubulo-, cysto-, and ciliogenesis [16,29,48,49]. Re-
cently, we found that the overexpression of Sec10 can rescue kidney
epithelial cells from the loss of epithelial barrier function induced by ox-
idative stress, and facilitate the recovery [29]. This rescue effect of Sec 10
overexpression was blocked by U0126 treatment [29]. In the present
study, we found that the expression of Sec10 increased in the recover-
ing kidney, and this increase is reduced by U0126 treatment. This sug-
gests that the regulation of Sec10 by ERK contributes to the recovery
process of acutely injured epithelial cells. In addition, it was reported
that Sec10 overexpression increased the length of primary cilia
[16,29,48,49]. Therefore, we conclude, based on all these results, that
ERK activation is necessary for the regulation of primary cilia length
and recovery following kidney injury.
2007H.-S. Jang et al. / Biochimica et Biophysica Acta 1832 (2013) 1998–2008Regardless of the origin of kidney interstitial ﬁbroblasts, the local
proliferation of interstitial ﬁbroblasts is a major factor in kidney ﬁ-
brosis [50]. Ponnusamy et al. reported that ERK mediates the death
of interstitial ﬁbroblasts [51]. In the present study, U0126 treatment
accelerated ﬁbroblast proliferation and ECM accumulation, whereas
it inhibited the proliferation of tubular epithelial cells, indicating
that ERK activation negatively regulates progression of ﬁbrosis, and
positively regulates the restoration of damaged tubular epithelial
cells. Supporting this idea, Chen et al. reported delayed recovery
from ischemic injury in the kidneys of proximal tubule-speciﬁc epi-
dermal growth factor receptor (EGFR) knock-out mice, which is
due to a decrease in ERK1/2 activation [38]. Moreover, disruption
of primary cilia leads to ﬁbrosis along with a deregulation of cell
growth and polarity [52]. TGF-β signaling is critical to progression
of kidney ﬁbrosis in experimental and clinical chronic kidney disease
[53]. Activation of NF-κB by TGF-β contributes to ﬁbrotic progression
through the regulation of the inﬂammatory response, which is one of
the mediators for ﬁbrogenesis [54–56]. Our present study showed
that inhibition of ERK results in an increase of TGF-β and activation
of NF-κB, indicating that enhanced signaling by these factors may
worsen ﬁbrotic progression in the kidneys of U0126-treatedmice. Fi-
nally, we suggest that ﬁbrotic changes in the kidney after I/R injury
may be controlled by cell-type speciﬁc regulation of ERK activation.
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